UBS Group »

Petros Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Petros Pharmaceuticals (PTPI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Petros Pharmaceuticals

Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024Jan 20255k10k15k010k20k30k40k
Value ($)Share countHistorical PTPI position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Petros Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Petros Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $5.1k 13k 0.39
2024-09-30 $16k 44k 0.36
2022-12-31 $2.6k 1.1k 2.33

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Petros Pharmaceuticals

Geode Capital Management
Vanguard Group
BlackRock
UBS Group
National Bank Of Canada /fi/
Advisor Group Holdings
Group One Trading
Bank of America Corporation
Morgan Stanley

View all funds holding Petros Pharmaceuticals